Global Vitiligo Market Growth

1
Global Vitiligo Market

2
Report Description and Highlights
Analyst View According to Renub Research Global
Vitiligo Market will be US 2.4 Billion by
the year 2024. Growing per capita healthcare
expenditure, improving healthcare infrastructure
in developing countries, growing diseases
awareness and expected approval of Vitiligo drugs
are some of the driving force for the growth of
this market. India and China are Key
Contributors in the Global Vitiligo Patient
Population Vitiligo patients population is
growing across all parts of the world. Patients
growth rates varies in the countries covered in
the report United States, United Kingdom, France,
Germany, Italy, India, China and Japan. India and
China are key contributors in the global vitiligo
patient population. Vitiligo Pipe Line Drugs are
Key Strength for this Market Place In the global
vitiligo market, vitiligo pipe line drugs will
play the major role for the growth of this
market. At present several drugs such as
ARN-4079, ATI-502, AX-1602, BOS-47, CCP-070,
Cerdulatinib (RVT-502), HuABC-2, Abatacept,
Topical Ruxolitinib, VLRX-001 etc. are in
preclinical, IND, Phase I, Phase II and Phase III
stage.


3
At present globally over 21 Million people has
suffered from this diseases.
It is expected that overall prevalence fall
between 1-2 percent of the total population.
Although Vitiligo disease can arise at any age,
it mostly occurs to young and middle age people.
 At present globally over 21 Million people has
suffered from this diseases. There are number of
drugs manufactures working for Vitiligo drugs
development across various parts of the globe
such as AXIM Biotechnologies, Boston
Pharmaceutical, Castle Creek Pharma, Dermavant
Sciences, JN Biosciences, Bristol-Myers Squibb,
Incyte Corporation, Clinuvel Pharmaceuticals etc.
and their Vitiligo drugs development are in
various stages.

Key Drugs Development Companies are working in
this Market Place Key drugs development
companies are working in this market place across
various parts of the globe such as AXIM
Biotechnologies, Boston Pharmaceutical, Castle
Creek Pharma, Dermavant Sciences, JN Biosciences,
Bristol-Myers Squibb, Incyte Corporation,
Clinuvel Pharmaceuticals etc. 
Read more here https//www.renub.com/global-vit
iligo-market-p.php
4
Global Forecast for Vitiligo Patients Population
Share
Forecast for Vitiligo Patients Population Share
(Percent), 2018 2024

Source Renub Research Analysis Note These are
dummy figures actual data given in the report
5
Segments, Countries, Drugs Profile and Companies
Covered in this Report
Segments - Global Vitiligo Market
    Vitiligo Patients Population    Vitiligo
Market

Countries - Global Vitiligo Market
United States United Kingdom
France Germany Italy India
China Japan
Global Vitiligo Market Drugs Profile Covered 
    ARN-4079    ATI-502    AX-1602  
 BOS-47    CCP-070     Cerdulatinib
(RVT-502)     HuABC-2     Abatacept   
 Topical Ruxolitinib     VLRX-001
Want more Information about this market? Request
a free sample copy https//www.renub.com/contact
us.php
6
Global Forecast for Vitiligo Market Share
(Percent)
Forecast for Vitiligo Market Share (Percent),
2018 2024

Source Renub Research Analysis Note These are
dummy figures actual data given in the report
7
Segments covered in this report
Companies Covered AXIM Biotechnologies
Incyte Corporation Bristol-Myers Squibb
Clinuvel Pharmaceuticals

Browse Related Report Diabetes Drug
Market United States Generic Drugs
Market Contact Us Tel [phone] (US),
91-120-421-9822 (INDIA) Email info_at_renub.com